Share This! Tweet This! Recommend Us! Print Page


Dermatology - Research

Dermatology Studies Accepting Participants

Allure AIN457 Psoriasis

Study Number: CAIN457A2323 – a multicenter, randomized, double-blind, placebo-controlled, 52-week study to demonstrate the efficacy, safety, and tolerability of subcutaneous Secukinumab injections with 2mL pre-filled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis—ALLURE.

Study Info

Principal Investigator: Andrew Pace, MD

Study Coordinator: Shannon Harris,, 253-301-6992